Abstract
Intravenous (IV) iron is the preferred and most efficacious treatment for patients with iron deficiency anemia (IDA) when oral iron cannot be used or where rapid iron delivery is required; however, IV infusions are invasive and e.g. require patients to be hospitalized or travel to specialist infusion units, which can have a detrimental effect on quality of life. The required number and duration of infusions varies between IV iron formulations. The aim of the present study was to elicit health state utility values (HSUVs) from a population of IDA-patients in China and to compare the results with a previous study conducted in the general population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
